If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Endoxan Side Effects Reported to FDA

The following Endoxan reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

The appearance of Endoxan on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

No Therapeutic Response

This is a report of a 31-year-old female patient (weight: NA) from DE, suffering from the following symptoms/conditions: complication of pregnancy, who was treated with Endoxan 1g (dosage: NA, start time: NS), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:

No Therapeutic Response

which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Endoxan 1g treatment in female patients, resulting in no therapeutic response side effect.

Infected Skin Ulcer, Pancytopenia, Cytomegalovirus Infection

This report suggests a potential Endoxan Infected Skin Ulcer, Pancytopenia, Cytomegalovirus Infection side effect(s) that can have serious consequences. A 64-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: microscopic polyangiitis and used Endoxan (dosage: NA) starting NS. Soon after starting Endoxan the patient began experiencing various side effects, including:

Infected Skin Ulcer

Pancytopenia

Cytomegalovirus Infection

Drugs used concurrently:

Prednisone

Prednisone

Rituximab

Azathioprine

Although Endoxan demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as infected skin ulcer, may still occur.

Failure To Thrive

This Failure To Thrive problem was reported by a health professional from JP. A 22-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Endoxan (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Endoxan, the patient experienced the following unwanted symptoms/side effects:

Failure To Thrive

Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as failure to thrive, may become evident only after a product is in use by the general population.

Exposure During Pregnancy

This is a report of a 29-year-old female patient (weight: NA) from DE. The patient developed the following symptoms/conditions: breast cancer and was treated with Endoxan 1g (dosage: NA) starting Feb 10, 2014. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:

Exposure During Pregnancy

This opens a possibility that Endoxan 1g treatment could cause the above reactions, including exposure during pregnancy, and some female subjects may be more susceptible.

Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Endoxan 1 G.

Febrile Bone Marrow Aplasia, Ileus Paralytic, Tendon Pain, Colitis

A 39-year-old male patient from FR (weight: NA) experienced symptoms, such as: burkitt^s lymphoma and was treated with Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable(dosage: NA). The treatment was initiated on Jul 24, 2012. After that a consumer reported the following side effect(s):

Febrile Bone Marrow Aplasia

Ileus Paralytic

Tendon Pain

Colitis

Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable efficacy:

Vincristine Sulfate

Mabthera

Doxorubicine Hydrochloride

Dexamethasone

Aracytine

Truvada

Truvada

Isentress

Bronchial Carcinoma

In this report, Endoxan 1g was administered for the following condition: granuloma.A 63-year-old male consumer from DE (weight: NA) started Endoxan 1g treatment (dosage: NA) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):

Bronchial Carcinoma

A possible interaction with other drugs could have contributed to this reaction: NA.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Endoxan 1g treatment could be related to the listed above side effect(s).

Serositis, Glaucoma, Osteoporosis

This is a report of the following Endoxan 1g side effect(s):

Serositis

Glaucoma

Osteoporosis

A 14-year-old female patient from JP (weight: NA) presented with the following condition: systemic lupus erythematosus and received a treatment with Endoxan 1g (dosage: NA) starting: 201302.The following concurrently used drugs could have generated interactions:

Predonine

Azanin

Selbex

Bonoteo

Domperidone

Alfarol

Granisetron

Methylprednisolone

The patient was hospitalized.This report suggests that a Endoxan 1g treatment could be associated with the listed above side effect(s).

Breast Cancer Recurrent, Bone Neoplasm

This Endoxan report was submitted by a 64-year-old female consumer from PL (weight: NA). The patient was diagnosed with: breast cancer and Endoxan was administered (dosage: NA) starting: 1997. The consumer developed a set of symptoms:

Breast Cancer Recurrent

Bone Neoplasm

Other drugs used simultaneously:

Methotrexate

Fluorouracil

Bisoprolol

Vinpocetine

Sertraline

Those unexpected symptoms could be linked to a Endoxan treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Gastrointestinal Obstruction

This is a report of a possible correlation between Endoxan use and the following symptoms/side effect(s):

Gastrointestinal Obstruction

which could contribute to an assessment of Endoxan risk profile.A 64-year-old female consumer from PL (weight: NA) was suffering from breast cancer recurrent and was treated with Endoxan (dosage: NA) starting 201302.Other concurrent medications:

Doxorubicin

Bisoprolol

Vinpocetine

Sertraline

The patient was hospitalized.

Pneumonia

A 63-year-old female patient from FR (weight: NA) presented with the following symptoms: NA and after a treatment with Endoxan 50 Mg, Comprim? Enrob? (dosage: NA) experienced the following side effect(s):

Pneumonia

The treatment was started on 201311. Endoxan 50 Mg, Comprim? Enrob? was used in combination with the following drugs: NA.The patient was hospitalized.This report could alert potential Endoxan 50 Mg, Comprim? Enrob? consumers.

Hypokalaemia, Pancytopenia, Vomiting, Diarrhoea

In this report, a 50-year-old female patient from FR (weight: NA) was affected by a possible Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable side effect.The patient was diagnosed with b-cell lymphoma. After a treatment with Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable (dosage: NA, start date: Dec 06, 2013), the patient experienced the following side effect(s):

Hypokalaemia

Pancytopenia

Vomiting

Diarrhoea

The following simultaneously used drugs could have led to this reaction: NA.The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable treatment.

Diplopia

This is a report of a 15-year-old male patient from PL (weight: NA), who used Endoxan (dosage: NA) for a treatment of lymphoma. After starting a treatment on NS, the patient experienced the following side effect(s):

Diplopia

The following drugs could possibly have interacted with the Endoxan treatment NA.Taken together, these observations suggest that a Endoxan treatment could be related to side effect(s), such as Diplopia.

Kaposi^s Sarcoma, Sepsis

This kaposi^s sarcoma side effect was reported by a health professional from FR. A 69-year-old female patient (weight:NA) experienced the following symptoms/conditions: plasma cell myeloma. The patient was prescribed Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable (dosage: NA), which was started on Mar 08, 2013. Concurrently used drugs: NA. When starting to take Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable the consumer reported the following symptoms:

Kaposi^s Sarcoma

Sepsis

The patient was hospitalized. These side effects may potentially be related to Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable.

Kaposi^s Sarcoma

This is a Endoxan 50 Mg, Comprim? Enrob? side effect report of a 63-year-old female patient (weight:NA) from FR, suffering from the following symptoms/conditions: amyloidosis, who was treated with Endoxan 50 Mg, Comprim? Enrob? (dosage:NA, start time: Aug 05, 2013), combined with:

Velcade

Dexamethasone

Januvia

Lipanthyl

Gaviscon

Bactrim

Phenoxymethylpenicillin

Zelitrex

, and developed a serious reaction and a kaposi^s sarcoma side effect. The patient presented with:

Kaposi^s Sarcoma

which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Endoxan 50 Mg, Comprim? Enrob? treatment in female patients suffering from amyloidosis, resulting in kaposi^s sarcoma.

Supraventricular Tachycardia, Tinnitus, Condition Aggravated

This report suggests a potential Endoxan 50 Mg, Comprim? Enrob?supraventricular tachycardia side effect(s) that can have serious consequences. A 58-year-old male patient from FR (weight:NA) was diagnosed with the following health condition(s): waldenstrom^s macroglobulinaemia and used Endoxan 50 Mg, Comprim? Enrob? (dosage: NA) starting Oct 28, 2013. Soon after starting Endoxan 50 Mg, Comprim? Enrob? the patient began experiencing various side effects, including:

Supraventricular Tachycardia

Tinnitus

Condition Aggravated

Drugs used concurrently:NA. Although Endoxan 50 Mg, Comprim? Enrob? demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as supraventricular tachycardia, may still occur.

Pneumonia, Non-hodgkin^s Lymphoma

This pneumonia problem was reported by a physician from IT. A 64-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): non-hodgkin^s lymphoma.On Nov 21, 2013 a consumer started treatment with Endoxan Baxter (dosage: NA). The following drugs/medications were being taken at the same time:

Myocet

Mabthera

Deltacortene

Vincristina Solfato

When commencing Endoxan Baxter, the patient experienced the following unwanted symptoms /side effects:

Pneumonia

Non-hodgkin^s Lymphoma

The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as pneumonia, may become evident only after a product is in use by the general population.

Diabetes Mellitus, Oral Candidiasis, Leukopenia, Deep Vein Thrombosis

This is a Endoxan Baxter side effect report of a 73-year-old male patient (weight: NA) from IT. The patient developed the following symptoms/conditions: antineutrophil cytoplasmic antibody positive,pulse abnormal and was treated with Endoxan Baxter (dosage: NA) starting NS. Concurrently used drugs:

Methylprednisolone

Prednisone

Prednisone

Rituximab

5% Platelet Lysate

Soon after that, the consumer experienced the following of symptoms:

Diabetes Mellitus

Oral Candidiasis

Leukopenia

Deep Vein Thrombosis

This opens a possibility that Endoxan Baxter could cause diabetes mellitus and that some male patients may be more susceptible.

This finding indicates that some patients can be more vulnerable to developing Endoxan I.v., Poeder Voor Oplossing Voor Injectie 200, 500, 1000 Mg side effects, such as progressive multifocal leukoencephalopathy.

Haemolysis, Hepatic Enzyme Increased

This haemolysis side effect was reported by a physician from CH. A 60-year-old male patient (weight:NA) experienced the following symptoms/conditions: bone marrow conditioning regimen,prophylaxis.The patient was prescribed Endoxan 1 G (dosage: NA), which was started on Dec 01, 2013. Concurrently used drugs:

Uromitexan Multidose 100 Mg/1 Ml

Uromitexan Multidose 100 Mg/1 Ml

Uromitexan Multidose 100 Mg/1 Ml

Busulfan

Busulfan

Atg Fresenius

Atg Fresenius

Metotrexate

.When starting to take Endoxan 1 G the consumer reported symptoms, such as:

Haemolysis

Hepatic Enzyme Increased

These side effects may potentially be related to Endoxan 1 G. The patient was hospitalized.

Intestinal Obstruction

This is a report of a 65-year-old female patient (weight: NA) from JP, suffering from the following symptoms/conditions: scleroderma, who was treated with Endoxan 1g (dosage: NA, start time: 201311), combined with:

Predonine

and developed a serious reaction and side effect(s). The consumer presented with:

Intestinal Obstruction

which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Endoxan 1g treatment in female patients, resulting in intestinal obstruction side effect.

Although Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as biliary tract disorder, may still occur.

Aortic Valve Incompetence

This Aortic Valve Incompetence problem was reported by a health professional from TR. A 19-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: takayasu^s arteritis. On NS this consumer started treatment with Endoxan 1g. Iv (dosage: NA). The following drugs were being taken at the same time:

Prednisolone

Dipyridamole

When commencing Endoxan 1g. Iv, the patient experienced the following unwanted symptoms/side effects:

Aortic Valve Incompetence

Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as aortic valve incompetence, may become evident only after a product is in use by the general population.

This is a report of a 44-year-old male patient (weight: NA) from PL. The patient developed the following symptoms/conditions: lymphoma and was treated with Endoxan (dosage: NA) starting NS. Concurrently used drugs:

Rituximab

Doxorubicin

Vincristine

Prednisone

Soon after that, the consumer experienced the following side effects:

Campylobacter Sepsis

Leukopenia

C-reactive Protein Increased

Pulmonary Embolism

The patient was hospitalized. This opens a possibility that Endoxan treatment could cause the above reactions, including campylobacter sepsis, and some male subjects may be more susceptible.

Top 10 Endoxan Side Effects for Men

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

You can use them to remind you of details that may alert your health care professional(s) to a problem

You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

Log Form

You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

Medicine Name and Dosage:

Side Effects

Scale

Date & Time

Other Medicine(s) or Treatment(s)

Scale: 1 = very mild to 10 = very bad

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Notice - The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Viewing and using of this information is subject to accepting Terms Of Use. PatientsVille.com
does not provide medical advice, diagnosis or treatment. The information regarding adverse reports, reviews and polls contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be
used to estimate the incidence of side effects, adverse drug reactions or for establishing or changing of patient treatments. Thank you for visiting Patientsville.com!